Peripheral actions and therapeutic potential in periphery

The Third Histamine Receptor: Selective Ligands as Potential Therapeutic Agents in CNS Disorders

Volumn , Issue , 2008, Pages 167-210

  Coruzzi, Gabriella ^a   Adami, Maristella ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863782222     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (325)

1. Windaus, A., and Vogt, W. 1907. Synthese des imidazolyl athylamins. Ber. Dtsch. Chem. Ges. 40: 3691-3695.
2. Dale, H.H., and Laidlaw, P.P. 1910. The physiological action of beta-imidazolylethylamine. J. Physiol. 41: 318-344.
3. Dale, H.H., and Laidlaw, P.P. 1919. Histamine shock. J. Physiol. 52: 355-390.
4. Bovet, D., and Staub, A.M. 1937. Action protectrice des ethers phenoliques an cours de l’intoxications histaminique. CR Soc. Biol. (Paris) 124: 547-549.
5. 2 receptors. Nature 236: 385-390.
6. 3) of histamine receptors. Nature 302: 832-837.
7. 4 receptor: a novel modulator of inflammatory and immune disorders. Pharmacol. Ther. 113: 594-606.
8. α -methylhistamine. Biochem. Biophys. Res. Commun. 168: 979-986.
9. 3 receptor in developing rat tissues. Mech. Dev. 105: 167-173.
10. 3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets. Pain 129: 76-92.
11. 3 Receptor: A Target for New Drugs, eds. R. Leurs, and H. Timmerman, pp. 59-111. Amsterdam: Elsevier.
12. 3 receptor drugs. Nat. Rev. Drug Discov. 4: 107-120.
13. 3 receptors. Nature 327: 117-123.
14. 3 receptor and its ligands. Progr. Med. Chem. 38: 279-308.
15. 4 ligands. Mini-Rev. Med. Chem. 4: 993-1000.
16. 4 receptors: structure-activity relationships of histamine derivatives. Br. J. Pharmacol. 147: 744-754.
17. Rangachari, P.K. 1992. Histamine: mercurial messenger in the gut. Am. J. Physiol. 262: G1-G13.
18. 3 receptor. In Molecular Targets for Drug Development: GI Diseases, eds. T.S. Gaginella, and A. Guglietta, pp. 239-267. Totowa: Humana Press.
19. Wood, J.D. 2006. Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies. Gut 55: 445-447.
20. Häkanson, R., and Sundler, F. 1991. Histamine-producing cells in the stomach and their role in the regulation of acid secretion. Scand. J. Gastroenterol. 180 (Suppl.): 88-94.
21. Hunyady, B., Zolyomi, A., Hoffman, B.J., and Mezey, E. 1998. Gastrin-producing endocrine cells: a novel source of histamine in the rat stomach. Endocrinology 139: 4404-4415.
22. Ekblad, E., Wahlestedt, C., Hakanson, R., Sundler, F., Watanabe, T., and Wada, H. 1985. Is histamine a neurotransmitter in the gut? Evidence from histidine decarboxylase immunocytochemistry. Acta Physiol. Scand. 123: 225-227.
23. Panula, P., Kaartinen, M., Macklin, M., and Costa, E. 1985. Histamine-containing peripheral neuronal and endocrine systems. J. Histochem. Cytochem. 33: 933-941.
24. Bertaccini, G., and Coruzzi, G. 1992. Histamine receptors in the digestive system. In The Histamine Receptor, eds. J.C. Schwartz, and H.L. Haas, pp. 183-230. New York: Wiley-Liss.
25. 4 receptor antagonists on experimental colitis in the rat. Eur. J. Pharmacol. 522: 130-138.
26. 3 receptor in the rat gastrointestinal tract. Inflamm. Res. 56 (Suppl. 1): S1-S2.
27. 3 receptor function in rat ileum and human colon. Naunyn- Schmiedeberg’s Arch. Pharmacol. 363: 133-138.
28. 3 R, in the human intestinal tract. Gut 55: 498-504.
29. Lindström, E., Chen, D., Norlen, P., Andersson, K., and Hakanson, R. 2001. Control of gastric acid secretion: the gastrin-ECL cell-parietal cell axis. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 128: 505-514.
30. 2 -receptors. Aliment. Pharmacol. Ther. 13: 1669-1674.
31. Aihara, T., Nakamura, E., Amagase, K. et al. 2003. Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future. Pharmacol. Ther. 98: 109-127.
32. Schubert, M.L. 2000. Gastric secretion. Curr. Opin. Gastroenterol. 16: 463-468.
33. 3 receptors, inhibits somatostatin and stimulates acid secretion in isolated mouse stomach. Gastroenterology 113: 1545-1552.
34. Vuyyuru, L., Schubert, M.L., Harrington, L., Arimura, A., and Makhlouf, G.M. 1995. Dual inhibitory pathways link antral somatostatin and histamine secretion in human, dog, and rat stomach. Gastroenterology 109: 1566-1574.
35. 3 -receptor regulation of vascular gastrin and somatostatin releases by the isolated rat stomach. Yale J. Biol. Med. 67: 113-121.
36. Kaneko, H., Konagaya, T., and Kusugami, K. 2002. Helicobacter pylori and gut hormones. J. Gastroenterol. 37: 77-86.
37. Konagaya, T., Kusugami, K., Yamamoto, H., Kaneko, H., Nagai, H., and Mitsuma, T. 1998. Effect of histamine on thyrotropin-releasing hormone and somatostatin secretion in rat stomach. Hepatogastroenterology 45: 567-572.
38. α -methylhistamine produced by Helicobacter pylori does not alter somatostatin release from cultured rabbit fundic D-cells. Gut 43: 176-181.
39. 3 -receptor agonist prodrug. Dig. Dis. Sci. 44: 2380-2385.
40. 3 receptor negatively coupled to phosphoinositide turnover in the human gastric cell line HGT1. J. Biol. Chem. 267: 25315-25320.
41. 3 receptor agonists and antagonists. Eur. J. Clin. Invest. 19: 1-10.
42. 3 receptors are not involved in the regulation of rat gastric secretion. Pharmacology 44: 190-195.
43. 3 -receptors. Br. J. Pharmacol. 115: 1326-1330.
44. Kwiecien, S., Brzozowski, T., Konturek, P.C. et al. 2001. Effect of central and peripheral actions of histamine and its metabolite N-α methyl histamine on gastric secretion and acute gastric lesions. J. Physiol. Pharmacol. 52: 625-638.
45. 3 receptors in the regulation of gastric functions. J. Physiol. Pharmacol. 52: 539-553.
46. 3 - receptor in vagal-, bethanecol-pentagastrin-induced gastric acid secretion in anaesthetized rats. Scand. J. Gastroenterol. 137: 754-758.
47. 3 receptors are involved in the control of gastric acid secretion in the conscious cat. Naunyn-Schmiedeberg’s Arch. Pharmacol. 343: 225-227.
48. 3 receptor in the control of gastric acid secretion in cats. Am. J. Physiol. 260: G631-G635.
49. 3 receptor-mediated inhibition of gastric acid secretion in conscious dogs. Naunyn-Schmiedeberg’s Arch. Pharmacol. 347: 61-65.
50. 3 receptors in the dog: an investigation into the site of action. Naunyn-Schmiedeberg’s Arch. Pharmacol. 350: 218-223.
51. 3 receptors in the dog. Scand. J. Gastroenterol. 31: 631-638.
52. Muller, M.J., Padol, I., and Hunt, R.H. 1993. Acid secretion in isolated murine gastric glands: classification of histaminergic and cholinergic receptors. Gastroenterology 104 (Suppl.): A151.
53. Sandvik, A.K., Lewin, M.J., and Waldum, H.L. 1989. Histamine release in the isolated vascularly perfused stomach of the rat: regulation by autoreceptors. Br. J. Pharmacol. 96: 557-562.
54. 3 receptors mediate antisecretory effects in the rat. Inflamm. Res. 53 (Suppl. 1): S25-S26.
55. Stanovnik, L., and Logonder-Mlinsek, M. 1996. Mast cell histamine in gastric secretiona study on the isolated portion of a guinea pig stomach. Pflugers Arch. 431 (Suppl. 2): R219-R220.
56. 3 -receptor activation inhibits cholinergic stimulation of acid secretion in isolated rabbit fundic glands. J. Pharmacol. Exp. Ther. 275: 1099-1103.
57. α~ methylhistamine on acid secretion in isolated cultured rabbit parietal cells: implications for Helicobacter pylori associated gastritis and gastric physiology. Gut 40: 14-19.
58. 3 receptor-mediated inhibition of endogenous acetylcholine release from the isolated, vascularly perfused rat stomach. Eur. J. Pharmacol. 392: 23-29.
59. 3 receptors in the stomach: physiological role in gastric acid regulation. Gastroenterology 98(Suppl.): A17.
60. Sobhani, I., Canedo, S., Alchepo, B. et al. 2002. Putative effect of Helicobacter pylori and gastritis on gastric acid secretion in cat. Am. J. Physiol. 282: G727-G734.
61. Vuyyuru, L., Harrington, L., Arimura, A., and Schubert, M.L. 1997. Reciprocal inhibitory paracrine pathways link histamine and somatostatin secretion in the fundus of the stomach. Am. J. Physiol. 273: G106-G111.
62. Prinz, C., Kajimura, M., Scott, D.R., Mercier, F., Helander, H.F., and Sachs, G. 1993. Histamine secretion from rat enterochromaffinlike cells. Gastroenterology 105: 449-461.
63. Kidd, M., Tang, L.H., Miu, K., Lawton, G.P., Sandor, A., and Modlin, I.M. 1996. Autoregulation of enterochromaffin-like cell histamine secretion via the histamine 3 receptor subtype. Yale J. Biol. Med. 69: 9-19.
64. Modlin, I.M., Lawton, G.P., Tang, L.H., Miu, K., and Schwartz, J.C. 1995. Histamine-3 receptor modulation of ECL histamine secretion and DNA synthesis. Gastroenterology 108: A992.
65. 3 receptors in isolated rabbit gastric glands. Am. J. Physiol. 262: G56-G61.
66. 3 receptors in isolated fundic mucosal cells. Am. J. Physiol. 265: G1039-G1044.
67. Payne, N.A., and Gerber, J.G. 1997. Effect of adenosine and histamine receptor stimulation on canine histamine release to pentagastrin. Digestion 58: 352-360.
68. α -methylhistamine. Gastroenterology 108: 959-966.
69. 3 receptor agonist. J. Med. Chem. 48: 2100-2107.
70. 3 -receptor antagonists. Eur. J. Pharm. Sci. 13: 249-259.
71. Marshall, B.J., and Warren, J.R. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315.
72. Howden, C.W. 1996. Clinical expressions of Helicobacter pylori infection. Am. J. Med. 100: 27S-32S.
73. Wessler, S., Hocher, M., Fischer, W. et al. 2000. Helicobacter pylori activates the histidine decarboxylase promoter through a mitogen-activated protein kinase pathway independent of pathogenicity island-encoded virulence factors. J. Biol. Chem. 275: 3629-3636.
74. Murray, S., Taylor, G.W., Karim, Q.N., Bliss, P., and Calam, J. 2000. N α-methylhistamine: association with Helicobacter pylori infection in humans and effects on gastric acid secretion. Clin. Chim. Acta 301: 181-192.
75. El-Omar, E., Penman, I., Dorrian, C.A., Ardill, J.E.S., and McColl, K.E.L. 1993. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 34: 1060-1065.
76. Queiroz, D.M., Mendes, E.N., Rocha, G.A. et al. 1993. Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand. J. Gastroenterol. 28: 858-864.
77. McGowan, C.C., Cover, T.L., and Blaser, M.J. 1996. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology 110: 926-938.
78. Kidd, M., Miu, K., Tang, L.H. et al. 1997. Helicobacter pylori lipopolysaccharide stimulates histamine release and DNA synthesis in rat enterochromaffin-like cells. Gastroenterology 113: 1110-1117.
79. α - methyl derivatives of histamine on gastric secretion of the rat. Pharmacol. Res. Commun. 5: 71-80.
80. 3 subtype. J. Pharmacol. Exp. Ther. 243: 874-880.
81. 3 receptors inhibit cholinergic neurotransmission. J. Pharmacol. Exp. Ther. 258: 325-331.
82. α -methylhistamine stimulates gastric acid secretion in duodenal ulcer patients via releasing gastrin. Eur. J. Pharmacol. 412: 181-185.
83. 2 receptors expressed in CHO cells. Gut 50: 786-789.
84. Klausz, G., Buzas, E., Scharek, P. et al. 2004. Effects of Helicobacter pylori infection on gastric inflammation and local cytokine production in histamine-deficient (histidine decarboxylase knock-out) mice. Immunol. Lett. 94: 223-228.
85. 3 receptors? Digestion 56: 145-152.
86. 3 -agonists and bradykinin. Eur. J. Gastroenterol. Hepatol. 7: 447-453.
87. Belcheva, A., Marazova, K., Lozeva, V., and Schunack, W. 1997. Effects of (R)-α- methylhistamine and its prodrug BP 2.94 on gastric mucosal lesions in cold/restraint stressed rats. Inflamm. Res. 46 (Suppl. 1): S113-S114.
88. Morini, G., Grandi, D., Krause, M., and Schunack, W. 1997. Gastric mucosal injury by nonsteroidal anti-inflammatory drugs is reduced by (R)-α-methylhistamine and its prodrugs in the rat. Inflamm. Res. 46(Suppl. 1): S101-S102.
89. Warzecha, Z., Dembinski, A., Brzozowski, T. et al. 2000. Gastroprotective effect of histamine and acid secretion on ammonia-induced gastric lesions in rats. Scand. J. Gastroenterol. 35: 916-924.
90. Konturek, P.C., Nikiforuk, A., Brzozowski, T. et al. 2004. Effect of N-α-methylhistamine on ulcer healing in rats. Inflamm. Res. 53(Suppl. 1): S27-S28.
91. Morini, G., Grandi, D., Arcari, M.L., Galanti, G., and Bertaccini, G. 1997. Histological effect of (R)-α-methylhistamine on ethanol damage in rat gastric mucosa: influence on mucus production. Dig. Dis. Sci. 42: 1020-1028.
92. 3- secretion in anaesthetized rats. Ital. J. Gastroenterol. 28: 520-522.
93. 3 receptors, sensory nerves and TGFα. XXXIVth Meeting of the Histamine Research Society, Bled, Slovenija.
94. Rydning, A., Lyng, O., Adamsen, B.L., Falkmer, S., Sandvik, A.K., and Gronbech, J.E. 2001. Mast cells are involved in the gastric hyperemic response to acid back diffusion via release of histamine. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G1061-G1069.
95. 3 receptors modulate reactive hyperemia in rat gut. J. Physiol. Pharmacol. 55: 651-661.
96. 3 receptor with high in vitro and in vivo activity. J. Med. Chem. 42: 4269-4274.
97. 3 receptors modulate cell proliferation and migration in rat oxyntic mucosa. Br. J. Pharmacol. 137: 237-244.
98. 3 receptor agonist (R)-α-methylhistamine throughout the rat gastrointestinal tract. Eur. J. Pharmacol. 538: 141-147.
99. 3 receptors in the gastroprotective effect of histamine against stress ulcers in rats. Eur. J. Pharmacol. 508: 211-221.
100. 3 -receptor differ in their gastroprotective activity in the rat. Inflamm. Res. 51(Suppl. 1): S75-S76.
101. 4 receptor as a new therapeutic target for inflammation. Trends Pharmacol. Sci. 26: 462-469.
102. 4 receptor antagonists JNJ7777120 and VUF6002. XXXVth Meeting of the European Histamine Research Society, Delphi, Greece.
103. 3 receptor agonist. J. Med. Chem. 47: 2414-2417.
104. 3 receptors mediate inhibition of noradrenaline release from intestinal sympathetic nerves. Br. J. Pharmacol. 129: 1387-1396.
105. 3 receptors and other prejunctional receptor systems in the isolated guinea pig duodenum. J. Pharmacol. Exp. Ther. 281: 393-399.
106. 2+ channels. J. Pharmacol. Exp. Ther. 270: 788-794.
107. 2 -adrenoceptors. Dig. Dis. Sci. 47: 1065-1072.
108. 1 receptor activation. Eur. J. Pharmacol. 237: 155-159.
109. 3 receptors in the control of gastrointestinal motility. An overview. J. Physiol. Paris 95: 67-74.
110. Fargeas, M.J., Fioramonti, J., and Bueno, L. 1989. Involvement of different receptors in the central and peripheral effects of histamine on intestinal motility in the rat. J. Pharm. Pharmacol. 41: 534-540.
111. α -methylhistamine on neuronal function in the guinea-pig oesophagus and ileum. J. Pharm. Pharmacol. 49: 1217-1221.
112. Todorov, S., Pozzoli, C., Zamfirova, R., and Poli, E. 2003. Prejunctional modulation of non-adrenergic non-cholinergic (NANC) inhibitory responses in the isolated guineapig gastric fundus. Neurogastroenterol. Motil. 15: 299-306.
113. 3 -selective ligands. Br. J. Pharmacol. 101: 621-624.
114. 3 -receptor selective drugs on the mechanical activity of guineapig small and large intestine. Br. J. Pharmacol. 102: 179-185.
115. 3 receptor desensitization in the guinea-pig ileum. Eur. J. Pharmacol. 341: 253-256.
116. 3 -receptors in the inhibition of cholinergic contractile responses of the guinea pig ileum. J. Pharmacol. Exp. Ther. 295: 607-613.
117. 3 receptor agonist, VUF 5810, on the guinea-pig isolated ileum. Inflamm. Res. 53 (Suppl. 1): S77-S78.
118. 3 -receptor-mediated inhibition of cholinergic and non-adrenergic, non-cholinergic neuro-effector transmission in guinea-pig isolated ileum. Eur. J. Pharmacol. 183: 1145.
119. 3 receptor. Eur. J. Pharmacol. 186: 343-347.
120. 3 receptors controlling non-adrenergic non-cholinergic contractions of the guinea pig isolated ileum. Br. J. Pharmacol. 105: 667-674.
121. 3 receptors do not modulate reflex-evoked peristaltic motility in the isolated guinea-pig ileum. Eur. J. Pharmacol. 327: 49-56.
122. 3 receptors on enteric ascending synaptic transmission in the guinea pig ileum. J. Pharmacol. Exp. Ther. 287: 952-957.
123. 3 receptors regulate acetylcholine release from the guinea pig ileum myenteric plexus. Life Sci. 48: PL63-PL68.
124. 3 receptor activation. Gastroenterology 104(Suppl.): A605.
125. 3 receptor-mediated inhibition of intestinal acetylcholine release: pharmacological characterization of signal transduction pathways. Naunyn-Schmiedeberg’s Arch. Pharmacol. 363: 193-202.
126. 3 receptors in the guinea pig ileum: evidence for a postjunctional location. J. Physiol. Paris 94: 1-4.
127. Tamura, K., Palmer, J.M., and Wood, J.D. 1988. Presynaptic inhibition produced by histamine at nicotinic synapses in enteric ganglia. Neuroscience 25: 171-179.
128. 3 receptors in the rabbit colon: species difference. Gen. Pharmacol. 28: 217-221.
129. 3 histamine receptor subtypes. Mol. Pharmacol. 38: 610-613.
130. 3 receptor models. Br. J. Pharmacol. 112: 1043-1048.
131. 3 receptor model. Naunyn-Schmiedeberg’s Arch. Pharmacol. 348: 498-503.
132. 3 receptors in isolated guinea pig pulmonary artery and ileum. Eur. J. Pharmacol. 294: 329-335.
133. 3 -receptors in guinea-pig cerebral cortex and ileum longitudinal muscle myenteric plexus. Br. J. Pharmacol. 128: 751-759.
134. 3 receptor heterogeneity. Naunyn-Schmiedeberg’s Arch. Pharmacol. 350: 375-379.
135. 3 receptor heterogeneity? J. Pharmacol. Exp. Ther. 276: 1009-1015.
136. Bauer, O., and Razin, E. 2000. Mast cell-nerve interactions. News Physiol. Sci. 15: 213-218.
137. Penissi, A.B., Rudolph, M.I., and Piezzi, R.S. 2003. Role of mast cells in gastrointestinal mucosal defense. Biocell 27: 163-172.
138. Cooke, H.J., and Reddix, R.A. 1994. Neural regulation of intestinal electrolyte transport. In Physiology of the Gastrointestinal Tract, ed. L.R. Johnson, pp. 2083-2132. New York: Raven Press.
139. Wood, J.D. 2004. Enteric neuroimmunophysiology and pathophysiology. Gastroenterology 127: 635-657.
140. 3 receptors: modulation of histamine-stimulated neural pathways influencing electrogenic ion transport in the guinea pig colon. J. Auton. Nerv. Syst. 50: 201-207.
141. Frieling, T., Cooke, H.J., and Wood, J.D. 1994. Neuroimmune communication in the submucous plexus of guinea pig colon after sensitization to milk antigens. Am. J. Physiol. 267: G1087-G1093.
142. 3 receptormediated suppression of inhibitory synaptic transmission in the submucous plexus of guinea-pig small intestine. Eur. J. Pharmacol. 397: 49-54.
143. Liu, S., Hu, H.Z., Gao, N. et al. 2003. Neuroimmune interactions in guinea pig stomach and small intestine. Am. J. Physiol. 284: G154-G164.
144. 2 receptors. Eur. J. Pharmacol. 546: 161-170.
145. Rangachari, P.K., and Prior, T. 1994. Functional subtyping of histamine receptors on the canine proximal colonic mucosa. J. Pharmacol. Exp. Ther. 271: 1016-1026.
146. 2 -receptors in the pig proximal colon. Inflamm. Res. 52: 79-85.
147. Keely, S.J., Stack, W.A., O’Donoghue, D.P., and Baird, A.W. 1995. Regulation of ion transport by histamine in human colon. Eur. J. Pharmacol. 279: 203-209.
148. Raithel, M., Matek, M., Baenkler, H.W., Jorde, W., and Hahn, E.G. 1995. Mucosal histamine content and histamine secretion in Crohn’s disease, ulcerative colitis and allergic enteropathy. Int. Arch. Allergy Immunol. 108: 127-133.
149. 1 antagonist dithiaden on acetic acid-induced colitis in rats. Physiol. Rev. 48: 65-72.
150. Tsunada, S., Fujimoto, K., Gotoh, Y. et al. 1994. Role of histamine receptors in intestinal repair after ischemia-reperfusion in rats. Gastroenterology 107: 1297-1304.
151. Nosalova, V., Cerna, S., Schunack, W., Grandi, D., and Coruzzi, G. 2001. Effects of (R)α-methylhistamine on experimental colitis. Inflamm. Res. 50(Suppl 2): S108-S109.
152. 3 -receptor agonist (R)-α-methylhistamine: from alkylaryl to substituted diaryl derivatives. Pharmazie 51: 720-726.
153. 3 -receptor agonist prodrug, on different models of colitis. Inflamm. Res. 51(Suppl. 1): S31-S32.
154. Perdue, M.H., Chung, M., and Gall, D.G. 1984. Effect of intestinal anaphylaxis on gut function in the rat. Gastroenterology 86: 391-397.
155. Barbara, G., Wang, B., Stanghellini, V. et al. 2007. Mast-cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel sindrome. Gastroenterology 132: 26-37.
156. Kreis, M.E., Jiang, W., Kirkup, A.J., and Grundy, D. 2002. Co-sensitivity of vagal mucosal to histamine and 5-HT in the rat jejunum. Am. J. Physiol. 283: G612-G617.
157. 1 receptors. Am. J. Physiol. 273: H2726-H2737.
158. Brunsden, A.M., and Grundy, D. 1999. Sensitization of visceral afferents to bradykinin in rat jejunum in vitro. J. Physiol. 521: 517-527.
159. Coelho, A.M., Fioramonti, J., and Bueno, L. 1998. Mast cell degranulation induces delayed rectal allodynia in rats: role of histamine and 5-HT. Dig. Dis. Sci. 43: 727-737.
160. McNeill, J.H. 1984. Histamine and the heart. Can. J. Physiol. Pharmacol. 62: 720-726.
161. Levi, R., Rubin, L.E., and Gross, S.S. 1991. Histamine in cardiovascular function and dysfunction: recent developments. In Handbook Experimental Pharmacology 97: Histamine and Histamine Antagonists, ed. B. Uvnas, pp. 347-383. Berlin: Springer.
162. 3 receptors. Can. J. Physiol. Pharmacol. 73: 558-564.
163. 3 receptors. General characterization and their function in the cardiovascular system. J. Physiol. Pharmacol. 49: 191-211.
164. 3 -receptors: a new frontier in myocardial ischemia. J. Pharmacol. Exp. Ther. 292: 825-830.
165. Levi, R., Rubin, L.E., and Gross, S.S. 1991. Histamine in cardiovascular function and dysfunction: recent developments. In Handbook Experimental Pharmacology 97, Histamine and Histamine Antagonist, ed. B. Uvnas, pp. 347-383. Berlin: Springer.
166. 3 -receptors inhibit sympathetic neurotransmission in guinea pig myocardium. Eur. J. Pharmacol. 204: 311-314.
167. 3 -receptors inhibit neurogenic microvascular leakage in airways. J. Appl. Physiol. 68: 21-25.
168. 3 receptors. Eur. J. Pharmacol. 273: 83-88.
169. 3 -receptorsmediated inhibition of calcitonin gene-related peptide release from cardiac C-fibers. Circ. Res. 78: 863-869.
170. Li, M., Hu, J., Chen, Z. et al. 2006. Evidence for histamine as a neurotransmitter in the cardiac sympathetic nervous system. Am. J. Physiol. 291: H45-H51.
171. 3 -receptors. Biochem. Biophys. Res. Commun. 306: 792-796.
172. Maggi, M.B., and Curtis, M.J. 1994. The antiarrhythmic effects of thioperamide in isolated rat heart. Br. J. Pharmacol. 113: 179P.
173. Fuder, H., Ries, P., and Schwartz, P. 1994. Histamine and serotonin released from the rat perfused heart by compound 48/80 or by allergen challenge influence noradrenaline or acetylcholine exocytotic release. Fundam. Clin. Pharmacol. 8: 477-490.
174. 3 receptors during ischemia/reperfusion in isolated rat hearts. J. Cardiovasc. Pharmacol. 43: 353-357.
175. 3 -receptor stimulation is unable to modulate noradrenaline release by the isolated rat heart during ischaemia-reperfusion. Fundam. Clin. Pharmacol. 13: 455-460.
176. 3 receptors in the pithed rat. Naunyn-Schmiedeberg’s Arch. Pharmacol. 347: 55-60.
177. 3 receptors. Eur. J. Pharmacol. 251: 43-51.
178. 3 receptors in the anaesthetized rat. Naunyn-Schmiedeberg’s Arch. Pharmacol. 351: 569-575.
179. 3 receptor activation. Eur. J. Pharmacol. 259: 211-214.
180. 3 -agonist attenuates the cardiovascular response to nicotine in rats. Pharmacol. Res. 31(Suppl.): 250.
181. 3 receptor-mediated inhibition of norepinephrine release from sympathetic terminals of guinea pig myocardium. Acta Pharmacol. Sin. 17: 425-428.
182. 2+ channels. J. Pharmacol. Exp. Ther. 269: 221-229.
183. 3 receptors in the conscious rabbit. Br. J. Pharmacol. 139: 1023-1031.
184. 3 -receptors in myocardial ischemia: their role as regulators of exocytotic norepinephrine release. J. Pharmacol. Exp. Ther. 271: 1259-1266.
185. 3 -receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia. Circ. Res. 78: 475-481.
186. 3 receptor on hypoxia-reoxygenation induced cardiac dysfunction in guinea pigs. Meth. Find. Exp. Clin. Pharmacol. 17: 30-35.
187. 3 agonist decreases arterial blood pressure in the guinea-pig. J. Pharm. Pharmacol. 45: 929-931.
188. 3 agonist is attenuated by an inhibitor of nitric oxide synthesis. J. Cardiovasc. Pharmacol. 27: 607-613.
189. 3 receptors. Br. J. Pharmacol. 107: 347-351.
190. Hutchison, R.W., and Hey, J.A. 1994. Pharmacological characterization of the inhibitory effect of (R)-α-methylhistamine on sympathetic cardiopressor responses in the pithed guinea-pig. J. Auton. Pharmacol. 14: 393-402.
191. 3 activation depresses cardiac function in experimental sepsis. J. Appl. Physiol. 85: 1693-1701.
192. 3 receptors inhibits renal noradrenergic neurotransmission in anesthetized dogs. Am. J. Physiol. 280: R1450-R1456.
193. 3 receptor blockade improves cardiac function in canine anaphylaxis. Am. J. Respir. Crit. Care Med. 160: 1142-1149.
194. 3 -histaminergic inhibition of cardiac sympathetic stimulation by R-α-methyl-histamine and its prodrug BP 2.94 in the dog. Br. J. Pharmacol. 126: 264-268.
195. 3 receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia. J. Pharmacol. Exp. Ther. 283: 494-500.
196. 3 -receptors in the human heart. Circ. Res. 77: 206-210.
197. Hill, S.J., Ganellin, C.R., Timmerman, H. et al. 1997. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev. 49: 253-278.
198. Schomig, A. 1990. Catecholamines in myocardial ischemia. Systematic and cardiac release. Circulation 82: 13-22.
199. 3 -receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings. Proc. Natl Acad. Sci. U.S.A. 99: 501-506.
200. 3 -receptor-induced attenuation of norepinephrine exocytosis: a decreased protein kinase A activity mediates a reduction in intracellular calcium. J. Pharmacol. Exp. Ther. 312: 272-280.
201. + exchange: a novel protective mechanism in myocardial ischemia. Proc. Natl Acad. Sci. U.S.A. 98: 2855-2859.
202. 3 receptors. Mol. Pharmacol. 63: 378-382.
203. 3 R pathway. Biochem. Pharmacol. 73: 1146-1156.
204. 3 -receptors in the tail artery from normotensive and spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 29: 801-807.
205. B receptors but not affected by histamine. Br. J. Pharmacol. 104: 478-482.
206. 3 receptor-mediated inhibition of the neurogenic vasopressor response in pithed rats. Eur. J. Pharmacol. 205: 307-310.
207. 3 receptors on sympathetic nerves of the pithed rat: activation by endogenous histamine and operation in spontaneously hypertensive rats. Naunyn-Schmiedeberg’s Arch. Pharmacol. 355: 261-266.
208. Räntfors, J., and Cassuto, J. 2003. Role of histamine receptors in the regulation of edema and circulation postburn. Burns 29: 769-777.
209. 3 receptors in the control of the vascular tone and oxygen uptake in the mesenteric circulation of the rat. J. Physiol. Pharmacol. 55: 255-267.
210. 3 -receptors inhibit electrically evoked endogenous noradrenaline overflow in the portal vein of freely moving rats. Naunyn-Schmiedeberg’s Arch. Pharmacol. 355: 256-260.
211. 3 -receptor blocker, facilitates vasopressor response to footshocks. Inflamm. Res. 47: 109-114.
212. 3 of histamine receptors on perivascular nerve terminals. Nature 327: 158-160.
213. 3 vasodilator mechanisms in the guinea pig ileum. Gastroenterology 108: 712-718.
214. Mink, S., Becker, A., Sharma, S., Unruh, H., Duke, K., and Kepron, W. 1999. Role of autacoids in cardiovascular collapse in anaphylactic shock in anaesthetized dogs. Cardiovasc. Res. 43: 173-182.
215. 3 receptors. Naunyn-Schmiedeberg’s Arch. Pharmacol. 346: 46-50.
216. 3 receptors in human saphenous vein and guinea pig ileum. Eur. J. Pharmacol. 366: 73-78.
217. 3 receptormediated endothelium-dependent relaxation in isolated rat aorta. Mediators Inflammation 4: 217-221.
218. + -ATPase. Mediators Inflammation 5: 69-74.
219. Adeagbo, A.S., and Oriowo, M.A. 1998. Histamine receptor subtypes mediating hyperpolarization in the isolated perfused rat mesenteric pre-arteriolar bed. Eur. J. Pharmacol. 347: 237-244.
220. Lau, W.H., Kwan, Y.W., Au, A.L., and Cheung, W.H. 2003. An in vitro study of histamine on the pulmonary artery of the Wistar-Kyoto and spontaneously hypertensive rats. Eur. J. Pharmacol. 470: 45-55.
221. Kostic, M.M., and Jakovljevic, V.L.J. 1996. Role of histamine in the regulation of coronary circulation. Physiol. Res. 45: 297-303.
222. Rosic, M., Collis, C.S., Anjelkovic, I.Z., Segal, M.B., Djuric, D., and Zlokovic, B.V. 1991. The effects of (R) α-methyl histamine on the isolated guinea pig aorta. Agents Actions 33(Suppl.): 283-287.
223. Pierpaoli, S., Marzocco, C., Bello, M.G., Schunack, W., Mannaioni, P.F., and Masini, E. 2003. Histaminergic receptors modulate the coronary vascular response in isolated guinea pig hearts. Role of nitric oxide. Inflamm. Res. 52: 390-396.
224. 3 agonist relaxes rabbit middle cerebral artery, in vitro. Eur. J. Pharmacol. 150: 393-396.
225. 3 -agonist is reduced by inhibitors of nitric oxide and prostacyclin synthesis. Br. J. Pharmacol. 105: 103-106.
226. 2+ current via GTP hydrolysis in rabbit saphenous artery. J. Physiol. 448: 133-152.
227. Neely, C.F., Matot, I., Haile, D., Nguyen, J., and Batra, V. 1995. Tone-dependent responses of histamine in feline pulmonary vascular bed. Am. J. Physiol. 268: H653-H661.
228. Champion, H.C., and Kadowitz, P.J. 1998. R-(-)-α-methyl-histamine has nitric oxidemediated vasodilator activity in the mesenteric vascular bed of the cat. Eur. J. Pharmacol. 343: 209-216.
229. Arai, M., and Chiba, S. 1999. Endothelium-dependent vasodilatation mechanisms by histamine in simian but not in canine femoral arterial branches. J. Auton. Pharmacol. 19: 267-273.
230. Martinez, A.C., Novella, S., Raposo, R., Recio, P., Labadia, A., and Costa, G. 1997. Histamine receptors in isolated bovine oviductal arteries. Eur. J. Pharmacol. 326: 163-173.
231. Bull, H.A., Courtney, P.F., Rustin, M.H., and Dowd, P.M. 1992. Characterization of histamine receptor sub-types regulating prostacyclin release from human endothelial cells. Br. J. Pharmacol. 107: 276-281.
232. Li, H., Burkhardt, C., Heinrich, U.R., Brausch, I., Xia, N., and Forstermann, U. 2003. Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation 107: 2348-2354.
233. Martinez, A.C., Prieto, D., and Raposo, R. 2000. Endothelium-independent relaxation induced by histamine in human dorsal penile artery. Clin. Exp. Pharmacol. Physiol. 27: 500-507.
234. Campos, H.A., Acuña, Y., Magaldi, L., and Israel, A. 1996. Alpha-fluoromethylhistidine, an inhibitor of histamine biosynthesis causes arterial hypertension. Naunyn-Schmiedeberg’s Arch. Pharmacol. 354: 627-632.
235. Barnes, P.J. 1992. Histamine receptors in the respiratory tract. In The Histamine Receptor, eds. J.C. Schwartz, and H.L. Haas, pp. 253-270. New York: Wiley-Liss.
236. 3 receptors: stimulation of IL-10 production. J. Immunol. 164: 2964-2970.
237. 3 receptors in murine allergic rhinitis. Laryngoscope 115: 1778-1784.
238. 3 -receptor modulation in rat lung and spleen. Clin. Sci. 87: 151-163.
239. Bockman, C.S., and Zeng, W. 2002. Histamine receptor type coupled to nitric oxide-induced relaxation of guinea-pig nasal mucosa. Auton. Autacoid Pharmacol. 22: 269-276.
240. 3 receptors in the trachea. Br. J. Pharmacol. 111: 445-454.
241. 3 agonist on the nonadrenergic non-cholinergic contraction in guinea-pig perfused bronchioles. J. Pharm. Pharmacol. 45: 955-958.
242. 3 -receptor for histamine: role of epithelium. Br. J. Pharmacol. 109: 960-966.
243. 3 receptor ligands in a model of bronchial hyper-responsiveness. Inflamm. Res. 45: 118-122.
244. 3 - receptors inhibit cholinergic neurotransmission in guinea-pig airways. Br. J. Pharmacol. 97: 13-15.
245. 3 receptors inhibit sympathetic modulation of airway microvascular leakage in allergic guinea pigs. Eur. J. Pharmacol. 254: 283-286.
246. 3 -receptors modulate nonadrenergic noncholinergic neural bronchoconstriction in guinea-pig in vivo. Eur. J. Pharmacol. 174: 49-55.
247. 1 -receptor activation. Eur. J. Pharmacol. 211: 421-426.
248. 3 receptors in isolated perfused rabbit lungs. Eur. J. Pharmacol. 277: 243-250.
249. 3 receptor agonist, on C-fibers, cholinergic fibers and mast cells in rabbit lungs in vitro. Eur. J. Pharmacol. 371: 23-30.
250. 3 receptor blockade produces nasal decongestion in an experimental model of nasal congestion. Am. J. Rhinol. 13: 391-399.
251. 3 receptor activation inhibits neurogenic sympathetic vasoconstriction in porcine nasal mucosa. Eur. J. Pharmacol. 452: 339-345.
252. Jolly, S., and Desmecht, D. 2003. Functional identification of epithelial and smooth muscle histamine-dependent relaxing mechanisms in the bovine trachea, but not in bronchi. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 134: 91-100.
253. 3 -receptors on cholinergic nerves in human aiways. Eur. J. Pharmacol. 163: 383-386.
254. 3 receptors in human nasal mucosa inhibits sympathetic vasoconstriction. Eur. J. Pharmacol. 484: 83-89.
255. 3 -receptor agonist on airway responses to sodium metabisulphite in asthma. Br. J. Clin. Pharmacol. 35: 55-57.
256. Fozard, J.R. 2000. BP-294 Ste Civile Bioprojet. Curr. Opin. Investig. Drugs 1: 86-89.
257. 3 receptor antagonists reach out for the clinic. Drug Discov. Today 10: 1613-1627.
258. Burns, S., and Hamley, P. 2005. Imidazol derivatives of piperidine as histamine antagonists. WO2005014579.
259. 2 receptors in human nasal mucosa. Acta Otolaryngol. 119: 588-591.
260. Nakaya, M., Takeuchi, N., and Kondo, K. 2004. Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates. Ann. Otol. Rhinol. Laryngol. 113: 552-557.
261. 4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis in my patent list. US2005090527.
262. Falus, A. 1994. Inflammation: the role of histamine. In Histamine and Inflammation, ed. A. Falus, pp. 63-77. Georgetown: Landes, R.G. Co.
263. Schneider, E., Rolli-Derkinderen, M., Arock, M., and Dy, M. 2002. Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol. 23: 255-263.
264. Tanaka, S., and Ichikawa, A. 2006. Recent advances in molecular pharmacology of the histamine systems: immune regulatory roles of histamine produced by leukocytes. J. Pharmacol. Sci. 101: 19-23.
265. Bartholeyns, J., and Fozard, J.R. 1985. Role of histamine in tumor development. Trends Pharmacol. Sci. 6: 123-125.
266. Idzko, M., La Sala, A., Ferrari, D. et al. 2002. Expression and function of histamine receptors in human monocyte-derived dendritic cells. J. Allergy Clin. Immunol. 109: 839-846.
267. 3 -receptor agonist prodrug. J. Pharmacol. Exp. Ther. 281: 1085-1094.
268. 3 -receptor agonist prodrug. J. Pharmacol. Exp. Ther. 295: 219-225.
269. 3 -receptors in the regulation of anaphylactic histamine release from isolated rat peritoneal mast cells. Jpn. J. Pharmacol. 66: 173-180.
270. Stenton, G.R., and Lau, H.Y. 1997. Effects of histamine agonists and antagonists on rat peritoneal mast cells. Inflamm. Res. 46(Suppl. 1): S15-S16.
271. Rozniecki, J.J., Letourneau, R., Sugiultzoglu, M., Spanos, C., Gorbach, J., and Theoharides, T.C. 1999. Differential effects of histamine 3 receptor-active agents on brain, but not peritoneal, mast cell activation. J. Pharmacol. Exp. Ther. 290: 1427-1435.
272. 3 receptors. Am. J. Respir. Cell. Mol. Biol. 14: 620-626.
273. 3 receptor on mast cells in the rat skin. Arch. Int. Pharmacodyn. 328: 307-314.
274. Brain, S.D., Newbold, P., and Kajekar, R. 1995. Modulation of the release and activity of neuropeptides in the microcirculation. Can. J. Physiol. Pharmacol. 73: 995-998.
275. 3 -receptors on the spontaneous and ConA induced-histamine release from human adenoidal mast cells. Agents Actions 33: 67-70.
276. He, S.H., Xie, H., and Fu, Y.L. 2005. Inhibition of tryptase release from human colon mast cells by histamine receptor antagonists. Asian. Pac. J. Allergy Immunol. 23: 35-39.
277. Raible, D.G., Lenahan, T., Fayvilevich, Y., Kosinski, R., and Schulman, E.S. 1994. Pharmacological characterization of a novel histamine receptor on human eosinophils. Am. J. Respir. Crit. Care Med. 149: 1506-1511.
278. 3 receptors. Allergy 46: 626-631.
279. 3 -antagonists on human leukocytes. Agents Actions 30: 137-139.
280. Muller, T., Myrtek, D., Bayer, H. et al. 2006. Functional characterization of histamine receptor subtypes in a human bronchial epithelial cell line. Int. J. Mol. Med. 18: 925-931.
281. Morichika, T., Takahashi, H.K., Iwagaki, H. et al. 2003. Histamine inhibits lipopolysaccharide- induced tumor necrosis factor-α production in an intercellular adhesion molecule-1- and B7.1-dependent manner. J. Pharmacol. Exp. Ther. 304: 624-633.
282. Takahashi, H.K., Iwagaki, H., Mori, S., Yoshino, T., Tanaka, N., and Nishibori, M. 2004. Histamine inhibits lipopolysaccharide-induced interleukin (IL)-18 production in human monocytes. Clin. Immunol. 112: 30-34.
283. 2 receptors. J. Immunol. 161: 2586-2593.
284. Kimata, H., Fujimoto, M., Ishioka, C., and Yoshida, A. 1996. Histamine selectivity enhances human immunoglobulin E (IgE) and IgG4 production induces by anti-CD58 monoclonal antibody. J. Exp. Med. 184: 357-364.
285. 3 receptor agonist (R)α-methylhistamine, on the inhibition of nociception and plasma extravasation in mice. Eur. J. Pharmacol. 541: 53-56.
286. 3 receptors regulate vascular permeability changes in the skin of mast cell-deficient mice. Int. Immunopharmacol. 3: 1563-1568.
287. 3 receptor blockade on cutaneous microvascular permeability elicited by compound 48/80. Life Sci. 76: 1787-1794.
288. Kahlson, G., Rosengren, E., and Steinhardt, C. 1963. Histamine-forming capacity of multiplying cells. J. Physiol. London. 169: 487-498.
289. LaBella, F.S., and Brandes, L.J. 2000. Interaction of histamine and other bioamines with cytochrome P450: implications for cell growth modulation and chemoprevention by drugs. Cancer Biol. 10: 47-53.
290. 1/2/ELK-1 pathway. Lab. Invest. 87: 473-487.
291. 3 receptors regulate ACTH release by AtT-20 cells. Eur. J. Pharmacol. 210: 31-35.
292. Medina, V., Cricco, G., Nunez, M. et al. 2006. Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biol. Ther. 5: 1462-1471.
293. 3 receptor in the developing CNS and brown fat suggests novel roles for histamine. Mol. Cell. Neurosci. 24: 614-622.
294. 3 histamine receptors in the rat cochlea. Neuroreport. 14: 423-425.
295. 3 receptors. J. Invest. Dermatol. 123: 116-123.
296. 3 receptors. Clin. Exp. Allergy 34: 456-459.
297. 3 antagonist-induced scratching behavior in mice. J. Pharmacol. Sci. 100: 297-302.
298. 2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment. J. Invest. Dermatol. 116: 261-265.
299. 3 receptor activation inhibits sympathetic-cholinergic responses in cats. Eur. J. Pharmacol. 257: 109-115.
300. 3 receptor agonist (R)α-methylhistamine in human skin. Br. J. Dermatol. 138: 622-626.
301. 3 receptor-mediated inhibition of sympathetically evoked mydriasis in rats. Eur. J. Pharmacol. 419: 55-59.
302. Yoshitomi, T., Ishikawa, H., Haruno, I., and Ishikawa, S. 1995. Effect of histamine and substance P on the rabbit and human iris sphincter muscle. Graefe’s Arch. Clin. Exp. Ophthalmol. 233: 181-185.
303. 3 receptors. Naunyn- Schmiedeberg’s Arch. Pharmacol. 348: 141-145.
304. Kamei, C.H. 1996. Effects of histamine and related compounds on the bovine iris dilator. Methods Find. Exp. Clin. Pharmacol. 18: 273-278.
305. 3 receptor-mediated inhibition of noradrenaline release in pig retina discs. Naunyn-Schmiedeberg’s Arch. Pharmacol. 342: 497-501.
306. Markwardt, K.L., Magnino, P.E., and Pang, I.H. 1997. Histamine induced contraction of human ciliary muscle cells. Exp. Eye Res. 64: 713-717.
307. 2+ signaling in cultured bovine corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 33: 3041-3049.
308. 3 receptors. Can. J. Physiol. Pharmacol. 74: 744-752.
309. 3 -receptor agonist prodrug, in a model of carbon tetrachloride-induced hepatotoxicity in rats. Folia Med. (Plovdiv) 46: 36-41.
310. Jennings, L.J., Salido, G.M., Pozo, M.J. et al. 1995. The source and action of histamine in the isolated gallbladder. Inflamm. Res. 44: 447-453.
311. 3 receptor antagonists, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450. Br. J. Pharmacol. 107: 161-164.
312. Marley, P.D., Thomson, K.A., Jachno, K., and Johnston, M.J. 1991. Histamine-induced increases in cyclic AMP levels in bovine adrenal medullary cells. Br. J. Pharmacol. 104: 839-846.
313. Neuhaus, J., Weimann, A., Stolzenburg, J.U., Dawood, W., Schwalenberg, T., and Dorschner, W. 2006. Histamine receptors in human detrusor smooth muscle cells: physiological properties and immunohistochemical representation of subtypes. World J. Urol. 24: 202-209.
314. Neuhaus, J., Oberbach, A., Schwalenberg, T., and Stolzenburg, J.U. 2006. Cultured smooth muscle cells of the human vesical sphincter are more sensitive to histamine than are detrusor smooth muscle cells. Urology 67: 1086-1092.
315. 3 - receptors participate in the effects of histamine on electrically-evoked contractions of rat vas deferens? Gen. Pharmacol. 22: 643-645.
316. 3 -receptors. Agents Actions 42: 95-100.
317. 3 -receptors modulate sympathetic neurotransmission in isolated guinea pig vas deferens. Acta Pharmacol. Sin. 15: 60-64.
318. Kim, Y.C., Davies, M.G., Lee, T.H., Hagen, P.O., and Carson, C.C. 1995. Characterization and function of histamine receptors in corpus cavernosum. J. Urol. 153: 506-510.
319. Montesino, H., Villar, M., Vega, E., and Rudolph, M.I. 1995. Histamine, a neuromodulator of noradrenergic transmission in uterine horns from mice in diestrus. Biochem. Pharmacol. 50: 407-411.
320. Rubio, E., Navarro-Badenes, J., Palop, V., Morales-Olivas, F.J., and Martinez-Mir, I. 1999. The effects of histamine on the isolated mouse uterus. J. Auton. Pharmacol. 19: 281-289.
321. Kitazawa, T., Shishido, H., Sato, T., and Taneike, T. 1997. Histamine mediates the muscle layer-specific responses in the isolated swine myometrium. J. Vet. Pharmacol. Ther. 20: 187-197.
322. Wagner, W., Ichikawa, A., Tanaka, S., Panula, P., and Fogel, W.A. 2003. Mouse mammary epithelial histamine system. J. Physiol. Pharmacol. 54: 211-223.
323. 3 receptor ligands on the serotonin uptake and release in rat blood platelets. Pol. J. Pharmacol. 48: 615-620.
324. 4 receptor antagonist with anti-inflammatory properties. J. Pharmacol. Exp. Ther. 309: 404-413.
325. 4 receptor stimulation in rats. Eur. J. Pharmacol. 544: 181-187.